Skip to main content

Icon Plc(ICLR-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low104.30
Day High107.98
Open:107.12
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Icon Plc

Select a category then submit the form to load news
Motley Fool
Perry Creek Capital Initiated a Position in Grindr Worth Nearly $6 Million. Is the Stock a Buy?
Newsfile
Lost Money on ICON Public Limited Company (ICLR)? Possible Fraud - Contact Levi & Korsinsky Today
Newsfile
Lost Money on ICON Public Limited Company (ICLR)? Possible Fraud - Contact Levi & Korsinsky Today
Newsfile
Protect Your Investment: Contact Levi & Korsinsky About the ICON Public Limited Company (ICLR) Investigation
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Icon (ICLR), Healthequity (HQY)
Tipranks
Analysts Offer Insights on Healthcare Companies: Icon (ICLR), Healthequity (HQY) and Danaher (DHR)
Tipranks
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Icon (ICLR) and Labcorp Holdings (LH)
Tipranks
Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON), MiMedx Group (MDXG) and Icon (ICLR)
Newsfile
Did You Suffer Losses in ICON Public Limited Company (ICLR)? Contact Levi & Korsinsky About Securities Fraud Claims
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Dexcom (DXCM) and Icon (ICLR)
Tipranks
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX)
Motley Fool
Trinity Street Sells $22 Million of Axalta Coating Systems Stock
Tipranks
ICON’s Role in Zealand Pharma’s Petrelintide Kidney Study: What Trial Completion Means for Investors
Tipranks
ICON Sets Timing for Release of Full-Year 2026 Financial Guidance
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Enovis (ENOV) and Icon (ICLR)
Tipranks
Barclays Sticks to Their Hold Rating for Icon (ICLR)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: BioNTech SE (BNTX), Icon (ICLR)
Tipranks
ICON plc to Present at Jefferies London Healthcare Conference
Business Wire
ICON plc to Present at the Jefferies London Healthcare Conference
Tipranks
New Phase 2b Trial by Icon Plc and Bavarian Nordic: A Closer Look at MVA-BN Vaccine Developments
Tipranks
Evercore ISI Reaffirms Their Buy Rating on Icon (ICLR)
Tipranks
Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Icon (ICLR) and Innovent Biologics (OtherIVBXF)
Tipranks
ICON plc’s Earnings Call: Balancing Growth and Challenges
Tipranks
Bank of America Securities Keeps Their Buy Rating on Icon (ICLR)
Tipranks
Icon (ICLR) Gets a Buy from Evercore ISI
Tipranks
ICON plc Reports Steady Q3 2025 Growth Amid Challenges
Tipranks
ICON Announces CEO Transition and Updates on Share Repurchase and Vaccine Study
Tipranks
Icon (ICLR) Gets a Buy from Truist Financial
Tipranks
Barclays Remains a Hold on Icon (ICLR)
Tipranks
ICON plc Reports Third Quarter 2025 Financial Results
Business Wire
ICON Reports Third Quarter 2025 Results
Tipranks
Bank of America Securities Reaffirms Their Buy Rating on Icon (ICLR)

Profile

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.